Sunrest Lifescience Ltd (SUNREST) is currently trading at 36.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Sunrest Lifescience Limited specializes in marketing OTC generic pharmaceutical products across multiple states in India, such as Maharashtra and Gujarat. The company recently transitioned from a private to a public entity, marking its ambition for growth and greater market penetration. Their product portfolio is diverse, covering therapeutic areas like anti-bacterial, anti-diabetic, and nutraceuticals, signaling a broad customer reach. Sunrest Lifescience relies on Trilend Pharmaceuticals for product manufacturing, emphasizing an integrated group approach to operations.

Over the past 52 weeks, Sunrest Lifescience Ltd has traded between a low of ₹24.58 and a high of ₹45.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Sunrest Lifescience Ltd has a market capitalization of approximately 15.45. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Sunrest Lifescience Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 4.15 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 15.45 Cr, Sunrest Lifescience Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Sunrest Lifescience Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Sunrest Lifescience Ltd is 4.15. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.